- Smart Health Technologies to Improve Long-Term Outcomes in PostMyocardial Infarction Patients, With a Focus on Electrocardiography
-
Cho KH, Kim JH, Kim MC, Sim DS, Hong YJ, Ahn Y, Jeong MH
- KMID: 2561214
- J Cardiovasc Interv.
- 2024 Jul;3(3):177-181.
- doi: 10.54912/jci.2024.0005
-
- CITED
-
- Close
- SHARE
-
- Close
- The History and Overview of Cardiac Rehabilitation and Secondary Prevention
-
Lee JY
- KMID: 2561216
- J Cardiovasc Interv.
- 2024 Jul;3(3):98-118.
- doi: 10.54912/jci.2024.0003
Indeed, many guidelines emphasize the crucial role of cardiac rehabilitation (CR) and secondary prevention in managing cardiovascular disease (CVD). Despite their importance, these programs are often underutilized in real-world clinical... -
- CITED
-
- Close
- SHARE
-
- Close
- Bioengineering the Heart: Harnessing Biomaterials for Innovative Cardiovascular Interventions
-
Jang WB, Kwon SM
- KMID: 2561212
- J Cardiovasc Interv.
- 2024 Jul;3(3):136-157.
- doi: 10.54912/jci.2024.0009
Biomaterials play a crucial role in cardiovascular interventions, influencing biocompatibility, mechanical properties, inflammatory responses, tissue regeneration, angiogenesis, and vascular remodeling. Herein, we comprehensively explored their diverse applications in cardiovascular medicine,... -
- CITED
-
- Close
- SHARE
-
- Close
- Protocol Update and Issues in EASTYLE Trial
-
Kim MH, Jeong YH
- KMID: 2561215
- J Cardiovasc Interv.
- 2024 Jul;3(3):89-97.
- doi: 10.54912/jci.2024.0004
The EASTYLE study is currently ongoing, based on the hypothesis that ticagrelor reduction and a 3-month aspirin removal strategy (Hybrid De-escalation) as part of the de-escalation strategy can reduce cardiovascular... -
- CITED
-
- Close
- SHARE
-
- Close
- “East Asian Paradox” Revisited: Precision Medicine for Antithrombotic Strategies Tailored to Atherothrombotic Cardiovascular Risks
-
Jeong YH, Tantry US, Omar M, Navarese E, Gorog DA, Gurbel PA
- KMID: 2561211
- J Cardiovasc Interv.
- 2024 Jul;3(3):119-135.
- doi: 10.54912/jci.2024.0006
Following percutaneous coronary intervention (PCI) in patients with coronary artery disease (CAD), patients may face a prolonged elevated risk of atherothrombotic events. This enduring vulnerability underscores the need for refined... -
- CITED
-
- Close
- SHARE
-
- Close
- The Role of Class I and IIa Histone Deacetylases in Atherosclerosis and Vascular Calcification
-
Kee HJ, Kim SH, Jeong SM, Sim DS, Hong YJ, Jeong MH
- KMID: 2561213
- J Cardiovasc Interv.
- 2024 Jul;3(3):158-176.
- doi: 10.54912/jci.2024.0011
Histone deacetylases (HDACs) are enzymes that remove the acetyl group of histone and non-histone proteins that are susceptible to post-translational modifications, such as phosphorylation, by a variety of stimuli. Unlike... -
- CITED
-
- Close
- SHARE
-
- Close
